These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 34163108)
1. Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis. Seen TK; Sayed M; Bilal M; Reyes JV; Bhandari P; Lourdusamy V; Al-Khazraji A; Syed U; Sattar Y; Bansal R World J Gastroenterol; 2021 Jun; 27(23):3238-3248. PubMed ID: 34163108 [TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question. Streba LA; Vere CC; Rogoveanu I; Streba CT World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859 [TBL] [Abstract][Full Text] [Related]
3. The Effects of Hepatic Steatosis on the Natural History of HBV Infection. Suliman I; Abdelgelil N; Kassamali F; Hassanein TI Clin Liver Dis; 2019 Aug; 23(3):433-450. PubMed ID: 31266618 [TBL] [Abstract][Full Text] [Related]
4. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice. Zhou JH; Cai JJ; She ZG; Li HL World J Gastroenterol; 2019 Mar; 25(11):1307-1326. PubMed ID: 30918425 [TBL] [Abstract][Full Text] [Related]
6. Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease. Makri E; Goulas A; Polyzos SA Arch Med Res; 2021 Jan; 52(1):25-37. PubMed ID: 33334622 [TBL] [Abstract][Full Text] [Related]
7. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Takahashi Y; Fukusato T World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438 [TBL] [Abstract][Full Text] [Related]
8. Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease. Satapathy SK; Sanyal AJ Semin Liver Dis; 2015 Aug; 35(3):221-35. PubMed ID: 26378640 [TBL] [Abstract][Full Text] [Related]
9. Non-invasive diagnosis of nonalcoholic fatty liver disease in patients with type 2 diabetes. Alhinai A; Patel K; Fonseca VA; Sebastiani G J Diabetes Complications; 2021 Sep; 35(9):107978. PubMed ID: 34183247 [TBL] [Abstract][Full Text] [Related]
10. Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma. Alqahtani SA; Chan WK; Yu ML Clin Liver Dis; 2023 May; 27(2):211-223. PubMed ID: 37024203 [TBL] [Abstract][Full Text] [Related]
11. Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience. Perumpail RB; Wong RJ; Ahmed A; Harrison SA Dig Dis Sci; 2015 Oct; 60(10):3142-8. PubMed ID: 26250831 [TBL] [Abstract][Full Text] [Related]
12. Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets. Chen Y; Wang W; Morgan MP; Robson T; Annett S Front Endocrinol (Lausanne); 2023; 14():1148934. PubMed ID: 37361533 [TBL] [Abstract][Full Text] [Related]
13. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease. Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986 [TBL] [Abstract][Full Text] [Related]
14. Association of nonalcoholic fatty liver disease and liver cancer. Schulz PO; Ferreira FG; Nascimento Mde F; Vieira A; Ribeiro MA; David AI; Szutan LA World J Gastroenterol; 2015 Jan; 21(3):913-8. PubMed ID: 25624725 [TBL] [Abstract][Full Text] [Related]